Abstract
Morphine was found to inhibit human granulocyte aggregation and ATP, thromboxane B2 (TxB2), and leukotriene B4 (LTB4) secretion during cell aggregation. None of the opioid peptides tested [(d-Ala2,d-Leu5)-enkephalin (DADL), (d-Ala2, N-Me-Phe4, Gly-ol5)-enkephalin (DAGO) ordynorphin 1-9 (Dyn 1-9)] was capable of mimicking morphine effects, while Dyn 1-9 per se induced TxB2 and LTB4 secretion from granulocytes. Morphine inhibition of both cell aggregation and ATP, but not of arachidonic acid metabolism product secretion, was prevented by naloxone. The naloxone-sensitive impairment by morphine of CD11b-CD18 complex surface expression observed could play a role in opioid inhibition of granulocyte activation.
Similar content being viewed by others
References
Wybran, J., T. Appelboom, J. P. Famaey, andA. Govaerts. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes.J. Immunol. 123:1068–1073.
Wybran, J. 1985. Enkephalins and endorphins as modifiers of the immune system: Present and future.Fed. Proc. 44:92–110.
Pert, C. B., M. R. Ruff, R. J. Weber andM. Herkenham. 1985. Neuropeptides and their receptors: A psychosomatic network.J. Immunol. 135:820–825.
Morley, J. E., N. E. Kay, G. F. Solomon, andN. P. Plotnikoff. 1987. Neuropeptides: Conductors of the immune orchestra.Life Sci. 41:527–534.
Blalock, J. E. 1984. The immune system as a sensory organ.J. Immunol. 132:1067–1074.
Plotnikoff, N. P., A. J. Murgo, G. C. Miller, C. N. Corder, andR. E. Faith. 1985. Enkephalins: Immunomodulators.Fed. Proc. 44:118–125.
Hazun E., K. J. Chang, andP. Cuatrecasas. 1979. Specific nonopiate receptors forβ-endorphin.Science 205:1033–1035.
Brown, S. L., S. Tokuda, L. C. Saland, andD. E. Van Epps. 1986. Opioid peptide effects on leukocyte migration.In Enkephalins and Endorphins—Stress and the Immune System. (N. P. Plotnikoff, R. E. Faith, A. J. Murgo, and R. A. Good, editors.) Plenum Press, New York. 367–386.
Murgo A. J., R. E. Faith, andN. P. Plotnikoff. 1986. Enkephalins: mediators of stressinduced immunomodulation.In Enkephalins and Endorphins—Stress and the Immune System. (N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good, editors.) Plenum Press, New York. 221–239.
Bryant, H. U., E. W. Bernton, andJ. W. Holaday. 1988. Morphine pellet-induced immunomodulation in mice: temporal relationships.J. Pharmacol. Exp. Ther. 245:913–918.
Van Epps, D. E. andL. Saland. 1984.β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear chemotaxis.J. Immunol. 132:3046–3051.
Van Epps, D. E., andS. L. Kutvirt. 1987. Modulation of human neutrophil adherence byβ-endorphin and met-enkephalin.J. Neuroimmunol. 15:219–227.
Simpkins, C. O., C. A. Dickey, andM. P. Fink. 1984. Human neutrophil migration is enhanced by beta-endorphin.Life Sci. 34:2251–2257.
Sharp, B. M., D. T. Tsukayama, G. Gekker, W. F. Keane, andP. K. Peterson. 1987.β-Endorphin stimulates human polymorphonuclear leukocyte superoxide production via a stereoselective opiate receptor.J. Pharmacol. Exp. Ther. 242:579–585.
Marcoli, M., G. Ricevuti, A. Mazzone, M. Bekkering, S. Lecchini, andG. M. Frigo. 1988. Opioid-induced modification of granulocyte function.Int. J. Immunopharmac. 10:425–432.
Rola-Pleszczynski, M. 1985. Immunoregulation by leukotrienes and other lipoxygenase metabolites.Immunol. Today 6:302–305.
Nagy, J. T., G. Foris, T. Fulop, G. Paragh, andN. P. Plotnikoff. 1988. Activation of the lipoxygenase pathway in the methionine enkephalin induced respiratory burst in human polymorphonuclear leukocytes.Life Sci. 42:2229–2305.
Ricevuti, G. andA. Mazzone. 1989. The neutrophil revisited.Inflammation 13:475–482.
Donahoe, R. M., J. K. A. Nicholson, J. J. Madden, F. Hollingsworth, D. A. Shafer, D. Gordon, P. Bokos, andA. Falek. 1986. Coordinate and independent effects of heroin, cocaine and alcohol abuse on T-cell E-rosette formation and antigen marker expression.Clin. Immunol. Immunopathol. 41:254–263.
Bradford M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem. 72:248–243.
Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood.Scand. J. Clin. Lab. Invest. (00 Suppl. 97) 77–92.
Buyon, J. P., S. B. Abramson, M. R. Philips, S. G. Slade, G. D. Ross, G. Weissmann, andR. J. Winchester. 1988. Dissociation between increased surface expression of Gp 165/95 and homotypic neutrophil aggregation.J. Immunol. 140:3156.
Craddock P. R., D. Hammerschmidt, J. C. White, A. Dalmasso, andH. S. Jacob. 1977. Complement (C5a) induced granulocyte aggregation in vitro.J. Clin. Invest. 60:260–267.
Ricevuti, G., L. Pacchiarini, A. Mazzone, D. Rota Scalabrini, G. Grignani, andS. C. Rizzo. 1987. Activation of arachidonic acid metabolism during aggregation of ploymorphonuclear granulocytes.Hematol. Rev. Commun. 1:329–339.
Wallis, W. J., D. D. Hickstein, B. R. Schwartz, C. H. June, H. D. Ochs, P. G. Beatty, S. J. Klebanoff, andJ. M. Harlan. 1986. Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils.Blood 67:1007–1013.
Muirhead, K. A., T. C. Schmitt, A. R. Muirhead. 1983. Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers.Cytometry 3:251–257.
Ruff, M. R., S. M. Wahl, S. Mergenhagen, andC. B. Pert. 1985. Opiate receptormediated chemotaxis of human monocytes.Neuropeptides 5:363–371.
Falke, N. E. andE. G. Fisher 1985. Cell shape of polymorphonuclear leukocytes is influenced by opioids.Immmunobiology 169:532–540.
Marcoli, M., G. Ricevuti, A. Mazzone, D. Pasotti, S. Lecchini, andG. M. Frigo. 1988. Stereoselective blockade by naloxone of opioid and non opioid-induced granulocyte activation.Int. J. Immunopharmacol. 11:53–61.
Lopker, A., L. G. Abood, W. Hoss, andF. J. Lionetti. 1980. Stereoselective muscarinic acethylcholine and opiate receptors in human phagocytic leukocytes.Biochem. Pharmacol. 29:1361–1367.
Falke, N. E. andE. G. Fisher 1986. Stereospecific opiate binding in living human polymorphonuclear leukocytes.Cell Biol. Int. Rep. 10:429–435.
Gyires, K., I. Budavari, S. Furst, andMolnar. 1985. Morphine inhibits the carrageenaninduced oedema and the chemoluminescence of leucocytes stimulated by zymosan.J. Pharm. Pharmacol. 37:100–104.
Simpkins, C. O., N. Ives, E. Tate, andM. Johnson. 1985. Naloxone inhibits superoxide release from neutrophils.Life Sci. 37:1381–1385.
Sharp, B. M., W. F. Keane, H. J. Suh, G. Gekker, D. Tsukayama, andP. K. Peterson. 1985. Opioid peptides rapidily stimulate superoxide production by human polymorphonuclear leukocytes.Endocrinology 117:793–800.
Badway, A. B., M. Evans, N. F. Punjani, andC. J. Morgan. 1983. Does naloxone always act as an opiate antagonist?Life Sci. 33:739–745.
Ricevuti, G., A. Mazzone, andJ. M. Harlan. 1988. Membrane glycoproteins of neutrophils and related diseases.Haematologica 73:415–422.
McCaine, H. W., I. B. Lamster, J. M. Bozzone, andJ. T. Grbic. 1982.β-Endorphin modulates human immune activity via non-opiate receptor mechanisms.Life Sci. 31:1919–1926.
Dave, J. R., N. Rubenstein, andR. L. Eskay. 1985. Evidence thatβ-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate-cyclase-adenosine 3′, 5′-monophosphate system.Endocrinology 117:1389–1395.
Mathews, P. M., C. J. Froelich, W. L. Sibbit, andA. D. Bankhurst. 1983. Enhancement of natural cytotoxicity byβ-endorphin.J. Immunol. 130:1658–1663.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mazzone, A., Ricevuti, G., Pasotti, D. et al. Peptide opioids and morphine effects on inflammatory process. Inflammation 14, 717–726 (1990). https://doi.org/10.1007/BF00916374
Issue Date:
DOI: https://doi.org/10.1007/BF00916374